These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9570677)

  • 1. Natural and therapy-induced anti-GM-CSF and anti-G-CSF antibodies in human serum.
    Revoltella RP; Laricchia-Robbio L; Moscato S; Genua A; Liberati AM
    Leuk Lymphoma; 1997 Dec; 26 Suppl 1():29-34. PubMed ID: 9570677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum.
    Laricchia-Robbio L; Moscato S; Genua A; Liberati AM; Revoltella RP
    J Cell Physiol; 1997 Nov; 173(2):219-26. PubMed ID: 9365526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy.
    Wadhwa M; Bird C; Fagerberg J; Gaines-Das R; Ragnhammar P; Mellstedt H; Thorpe R
    Clin Exp Immunol; 1996 May; 104(2):351-8. PubMed ID: 8625532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF.
    Wadhwa M; Skog AL; Bird C; Ragnhammar P; Lilljefors M; Gaines-Das R; Mellstedt H; Thorpe R
    Clin Cancer Res; 1999 Jun; 5(6):1353-61. PubMed ID: 10389919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
    Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B; Ciaglo A; Schatz H; Coakley G
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoietic growth factors and anti-infective respiratory defenses].
    Gagnadoux F; Diot P; Boissinot E; Lemarié E
    Rev Mal Respir; 1997 Apr; 14(2):93-9. PubMed ID: 9198845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro.
    Revoltella RP; Laricchia Robbio L; Liberati AM; Reato G; Foa R; Funaro A; Vinante F; Pizzolo G
    Cell Immunol; 2000 Sep; 204(2):114-27. PubMed ID: 11069719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of granulocyte-macrophage (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) by rat clonal osteoblastic cell population CRP 10/30 and the immortalized cell line IRC10/30-myc1 stimulated by tumor necrosis factor alpha.
    Felix R; Cecchini MG; Hofstetter W; Guenther HL; Fleisch H
    Endocrinology; 1991 Feb; 128(2):661-7. PubMed ID: 1703481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of development and characteristics of antibodies induced in cancer patients against yeast expressed rDNA derived granulocyte macrophage colony stimulating factor (GM-CSF).
    Rini B; Wadhwa M; Bird C; Small E; Gaines-Das R; Thorpe R
    Cytokine; 2005 Jan; 29(2):56-66. PubMed ID: 15598439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of a sensitive radioimmunoassay for human granulocyte-macrophage colony-stimulating factor able to measure normal concentrations in blood.
    Mortensen BT; Schifter S; Pedersen LB; Jensen AN; Hovgaard D; Nissen NI
    Exp Hematol; 1993 Sep; 21(10):1366-70. PubMed ID: 8359236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
    Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and expression of granulocyte- and macrophage-colony-stimulating factors in newborns: their roles in leukocytosis at birth.
    Ishii E; Masuyama T; Yamaguchi H; Saito S; Irie K; Nomiyama M; Motoyoshi K; Miyazaki S
    Acta Haematol; 1995; 94(1):23-31. PubMed ID: 7544522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus.
    Revoltella RP; Laricchia Robbio L; Moscato S; Vinante F; Fasciani A; Liberati AM; Reato G; Foa R
    Hematol J; 2001; 2(3):161-71. PubMed ID: 11920241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.